Contains viable, selected strains of human adenovirus type 4 and human adenovirus type 7 prepared in human-diploid fibroblast cell cultures (strain wi-38); virus strains have not been attenuated; cells are grown and the virus growth maintained in dulbecco's modified eagle's medium, fetal bovine serum, and sodium bicarbonate; approved for use in military populations 17-50 years of age; indicated for active immunization for the prevention of febrile acute respiratory disease caused by adenovirus type 4 and type 7; carton consists of one bottle of 100 tablets adenovirus type 4 (ndc 51285-174-02) and one bottle of 100 tablets adenovirus type 7 (ndc 51285-175-02); store refrigerated between 2-8 degrees c (35-46 degrees f); do not freeze; keep bottle tightly closed and protect from moisture; do not remove desiccant canister from bottle; prescription only; for oral administration; dosage: one tablet of adenovirus type 4 component and one tablet of adenovirus type 7 component
NSN 6645-01-432-7943
NSN 5975-01-621-9484
NSN 5855-01-537-6504
NSN 6240-01-124-1049
NSN 5965-01-323-7225
NSN 5965-00-150-1144
NSN 5920-01-360-2770
NSN 5945-01-518-1515
NSN 6650-00-952-4500
NSN 5905-01-095-8373
NSN 5925-01-502-4101
NSN 6650-00-035-9297